Tharin Limsakun
EduInnovation(US)
Publications by Year
Research Areas
Hemophilia Treatment and Research, Platelet Disorders and Treatments, Cholinesterase and Neurodegenerative Diseases, Neuropeptides and Animal Physiology, Blood Coagulation and Thrombosis Mechanisms
Most-Cited Works
- → Synthesis and Biological Evaluation of Thiol-Based Inhibitors of Glutamate Carboxypeptidase II: Discovery of an Orally Active GCP II Inhibitor(2003)106 cited
- → Efficacy and safety of rVIII-SingleChain: results of a phase 1/3 multicenter clinical trial in severe hemophilia A(2016)86 cited
- → The central nervous system effects, pharmacokinetics and safety of the NAALADase‐inhibitor GPI 5693(2005)67 cited
- → Comparative pharmacokinetics of rVIII‐SingleChain and octocog alfa (Advate®) in patients with severe haemophilia A(2016)56 cited
- → Controlled, multidose, pharmacokinetic evaluation of two extended-release carbamazepine formulations (carbatrol and tegretol-XR)(1998)38 cited
- → Phase 1 Dose Escalation Study of MDM2 Inhibitor DS-3032b in Patients with Hematological Malignancies - Preliminary Results(2016)37 cited
- → Pharmacokinetics and pharmacodynamics of antiulcer agents in llama(2001)25 cited
- → First‐in‐Human Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of an Oral Formulation of DS‐1040, an Inhibitor of the Activated Form of Thrombin‐Activatable Fibrinolysis Inhibitor, in Healthy Subjects(2019)12 cited
- → Phase I studies of the safety, tolerability, pharmacokinetics, and pharmacodynamics of DS‐1211, a tissue‐nonspecific alkaline phosphatase inhibitor(2022)9 cited
- → Safety, efficacy, and PK/PD of vorasidenib in previously treated patients with mIDH1/2 hematologic malignancies: A phase 1 study(2023)9 cited